The vaccines will be shipped in 2009 2009.
Bavarian Nordic to provide IMVAMUNE vaccines Bavarian Nordic A/S declared today that it has signed a agreement with the armed service of an undisclosed EU nation for the delivery of a little order for IMVAMUNE. The vaccines will be shipped in 2009 2009 affects males . The worthiness and size of the contract is undisclosed. This marks the very first time Bavarian Nordic enters a agreement with an EU nation for the delivery of IMVAMUNE, and it demonstrates that there is a real demand within EU for brand-new and safer smallpox vaccines for preparedness stockpiles.
Bavarian Nordic updates in vaccine project pipeline In a business update, Danish-based biopharmaceutical company Bavarian Nordic, reported a genuine number of advancements in its vaccine task pipeline. Clinical advancement of IMVAMUNE as a secure smallpox vaccine is normally proceeding as planned. Stage III research with IMVAMUNE in healthful subjects are anticipated to become initiated in 2008. Bavarian Nordic received an progress payment of $50 million from the Division of Health insurance and Human Solutions as allowed beneath the RFP-3 agreement.